|
|
|
|
|
Welcome to Reproductive Medicine Network funded by
NICHD
|
News Update
RMN to Launch Additional Clinical Trials in Reproductive Medicine in 2010
The Reproductive Medicine Network (RMN), established in 1989 and funded by Eunice Kennedy Shriver
National Institute of Child Health and Human Development (NICHD), is a cooperative effort of
seven clinical sites, a data coordinating center, and the Reproductive Science Branch of the NICHD, charged with conducting and publishing high quality clinical studies in
reproductive medicine.
In 2009, the RMN launched the following clinical trial that addresses female infertility:
For infertile women diagnosed with Polycystic Ovary Syndrome (PCOS), the RMN Pregnancy in PCOS (PPCOS) trial is aimed at determining the efficacy of
several medications designed to aid in the achievement of conception and a live birth outcome. For more information on the study please go to
http://clinicaltrials.gov/ct2/show/NCT00719186.
In 2010, the RMN is launching more clinical trails to address three additional aspects in reproductive medicine - namely male infertility, in vitro fertilization (IVF), and multiple gestations as a result of
ovarian stimulation. - The following clinical trials will begin in late spring:
For men with impaired fertility, an abnormal semen analysis and a palpable varicocele, the RMN Varicocele trial will examine the effect of
Microsurgical Varicocelectomy on conception and a live birth outcome. For more information on the study please go to
http://clinicaltrials.gov/ct2/show/NCT00767338.
For couples who undergo In Vitro Fertilization (IVF) procedures, the RMN Physiologic Oxygen (PhOx) study is aimed at determining a more effectual
oxygen level in the culture media which will improve live birth rates. For more information on the study please go to http://clinicaltrials.gov/ct2/show/study/NCT01010386.
For couples with unexplained infertility in whom the female partner ovulates regularly, the RMN Multiple Intrauterine Gestations (AMIGOS) trial tries to identify an ovarian stimulation
agent that will help couples successfully obtain their goal of delivering a healthy child with low rates of multiple gestational pregnancies. For more information on the study please go to http://clinicaltrials.gov/ct2/show/study/NCT01044862.(The AMIGOS study is sponsored by a grant from the American Recovery and Reinvestment Act (ARRA)
of 2009.)
|
| |
Last Revised:
Thursday, 21-Jul-2011 15:45:45 EDT
|